STOCK TITAN

Trulieve Cannabis (OTCQX: TCNNF) raises CEO and key executive salaries

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Trulieve Cannabis Corp. reported executive compensation changes. Effective January 1, 2026, the Compensation Committee raised CEO Kim Rivers’ base salary from $850,000 to $900,000. Chief Production Officer Kyle Landrum’s base salary increased from $350,000 to $375,000, and Chief Technology Officer Nilyum Jhala’s salary also rose from $350,000 to $375,000.

For additional recognition of 2025 performance, Mr. Landrum received an extra 2025 bonus of $25,000, and Mr. Jhala received an extra 2025 bonus of $50,000 for services rendered.

Positive

  • None.

Negative

  • None.
false000175419500017541952026-02-122026-02-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 12, 2026
___________________
TRULIEVE CANNABIS CORP.
(Exact Name of Registrant as specified in its charter)
___________________
British Columbia000-5624884-2231905
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
3494 Martin Hurst Road
Tallahassee, FL 32312
(Address of principal executive offices and zip code)

(850) 298-8866
(Registrant’s telephone number, including area code)
Not Applicable
(Registrant’s name or former address, if change since last report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
N/AN/AN/A



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o

5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e)    On February 12, 2026, the Compensation Committee of the Board of Directors of Trulieve Cannabis Corp. (the “Company”) approved an increase in the base salary for Kim Rivers, Chief Executive Officer of the Company, from $850,000 to $900,000. Additionally, the Company approved (i) an increase in the base salary for Kyle Landrum, Chief Production Officer of the Company, from $350,000 to $375,000, and (ii) an increase in the base salary for Nilyum Jhala, Chief Technology Officer of the Company, from $350,000 to $375,000. Each of the above increases in salary is effective as of January 1, 2026.
Mr. Landrum was also granted an additional 2025 bonus of $25,000 and Mr. Jhala was granted an additional 2025 bonus of $50,000 for services rendered.

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Trulieve Cannabis Corp.
By:/s/ Eric Powers
Name:Eric Powers
Title:Chief Legal Officer
Date: February 18, 2026

FAQ

What executive compensation changes did Trulieve Cannabis Corp. (TCNNF) approve?

Trulieve Cannabis Corp. approved base salary increases for its CEO, Chief Production Officer, and Chief Technology Officer, along with additional 2025 bonuses for two executives, reflecting updated compensation decisions by the company’s Compensation Committee effective at the start of 2026.

How much did Trulieve (TCNNF) increase CEO Kim Rivers’ base salary?

Trulieve increased CEO Kim Rivers’ base salary to $900,000, up from $850,000. This change was approved by the Compensation Committee and is effective as of January 1, 2026, updating her annual cash compensation level going forward.

Which Trulieve (TCNNF) executives received salary increases in this 8-K filing?

CEO Kim Rivers, Chief Production Officer Kyle Landrum, and Chief Technology Officer Nilyum Jhala all received base salary increases. Each raise was approved by the Compensation Committee and became effective on January 1, 2026, adjusting their ongoing executive pay packages.

What additional 2025 bonuses did Trulieve (TCNNF) grant to its executives?

Trulieve granted an additional 2025 bonus of $25,000 to Chief Production Officer Kyle Landrum and $50,000 to Chief Technology Officer Nilyum Jhala. These bonuses were awarded for services rendered during 2025, on top of their base salary increases.

When do the new Trulieve (TCNNF) executive salaries become effective?

The new executive base salaries at Trulieve become effective as of January 1, 2026. The Compensation Committee approved these changes on February 12, 2026, aligning the updated pay levels with the start of the 2026 calendar year.

Which Trulieve (TCNNF) board committee approved the compensation changes?

The Compensation Committee of Trulieve’s Board of Directors approved the salary increases and additional 2025 bonuses. This committee oversees executive pay decisions and authorized the updated compensation for the CEO, Chief Production Officer, and Chief Technology Officer.

Filing Exhibits & Attachments

3 documents
Trulieve Cannabis Corp

OTC:TCNNF

TCNNF Rankings

TCNNF Latest News

TCNNF Latest SEC Filings

TCNNF Stock Data

1.35B
184.53M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Quincy